Search
for

    Sort by

    Research 121–150 of 1000+

    1. Adverse cutaneous effects of psychotropic medications Expert Review of Dermatology · 2013 · 6 citations
    2. A Unique Acquired Athletic Dermatologic Condition in a Half Marathon Participant: An Autobiographical Case Report of Sports-Associated Clothing Related Axillary Tangled Clumped Hairs (SCRATCH) Cureus · 2025
    3. Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report Cureus · 2026
    4. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun ˜The œFASEB journal · 2005 · 349 citations
    5. Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options Allergy · 2006 · 130 citations
    6. Neuronal plasticity of the “brain–skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways Journal of Molecular Medicine · 2007 · 66 citations
    7. Hypersensitivity Reactions to Anticoagulant Drugs Current Pharmaceutical Design · 2008 · 28 citations
    8. Updates in the understanding and treatments of skin & hair disorders in women of color International Journal of Women's Dermatology · 2015 · 10 citations
    9. Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches Scientific Reports · 2025
    10. Oral Manifestations of Hematologic and Nutritional Diseases Otolaryngologic Clinics of North America · 2010 · 50 citations
    11. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas British Journal of Dermatology · 2003 · 68 citations
    12. Dermatologic Manifestations of Human Immunodeficiency Virus Infection Mayo Clinic Proceedings · 1992 · 53 citations
    13. Dermatologic manifestations of COVID‐19: a comprehensive systematic review International Journal of Dermatology · 2020 · 27 citations
    14. Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects Cutaneous and Ocular Toxicology · 2013 · 18 citations
    15. Drug eruptions in dermatology Expert Review of Dermatology · 2011 · 11 citations
    16. Aberrant inflammasome activation as a driving force of human autoimmune skin disease Frontiers in immunology · 2023 · 3 citations
    17. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    18. British Society for Dermatopathology British Journal of Dermatology · 2011
    19. Oral cyclosporin does not arrest progression of androgenetic alopecia British Journal of Dermatology · 2008
    20. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy Springer eBooks · 2018
    21. The Dynamics of the Skin’s Immune System International Journal of Molecular Sciences · 2019 · 306 citations
    22. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations
    23. Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts Clinics in Dermatology · 2011 · 19 citations
    24. What′s new in cicatricial alopecia? Indian Journal of Dermatology, Venereology and Leprology · 2013 · 16 citations
    25. Novel therapies for alopecia areata: The era of rational drug development The Journal of Allergy and Clinical Immunology · 2017 · 9 citations
    26. Non‐infective mucocutaneous presentations of human immunodeficiency virus infection Australasian Journal of Dermatology · 1997 · 8 citations
    27. Cutaneous Markers of Disorders Affecting Adult Horses Clinical Techniques in Equine Practice · 2005 · 5 citations
    28. Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database Frontiers in Pharmacology · 2025 · 2 citations
    29. Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons Dermatology and Therapy · 2025 · 1 citations
    30. Cutaneous Lupus Erythematosus Springer eBooks · 2017